Search

Author/Creator Bhagwat, B.

1. Characterization of MK-4166, a clinical agonistic mAb that targets human GITR and inhibits the generation and activity of Tregs. (December 2016)

Authors:
Sukumar, S.; Wison, D.; Yu, Y.; Wong, J.; Naravula, S.; Ermakov, G.; Bhagwat, B.; Grein, J.; Churakova, T.; Mangadu, R.; Sriram, V.; Bailey, W.; Herzyk, D.; Mcclanahan, T.; Willingham, A.; Beebe, A.; Sadekova, S.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy. (December 2016)

Authors:
Phan, U.; Ueda, R.; Mangadu, R.; Sathe, M.; Rimmer, E.; Vives, F.; Ayanoglu, G.; Yu, Y.; Wong, J.; Sadekova, S.; McClanahan, T.; Bhagwat, B.; Willingham, A.; Raubertas, R.; Kastelein, R.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search